Paper5769741
The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis.
Asbury AK and 2 others. Medicine (Baltimore), 1969. Cited by 735 papers, by iCite.
Cite this record
ConductScience Library. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Papers, record 5769741. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5769741
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypersensitivity, Delayed | Major topic |
| Nerve Degeneration | Major topic |
| Polyradiculopathy | Major topic |
| Adult | |
| Aged | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
Cited by150
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 735 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42282969 | A recombinant IgG1 Fc-domain protein ameliorates inflammatory demyelinating peripheral neuropathy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42282969 | PubMed |
| 41774118 | Sinomenine ameliorates experimental autoimmune neuritis by suppressing pro-inflammatory immune components and restoring immune balance. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41774118 | PubMed |
| 40416578 | Tacrolimus associated Guillain-Barre syndrome. | Arch Clin Cases | 2025 | https://conductscience.org/library/papers/40416578 | PubMed |
| 40415889 | Endoneurial immune interplay in peripheral nerve repair: insights and implications for future therapeutic interventions. | Front Neurosci | 2025 | https://conductscience.org/library/papers/40415889 | PubMed |
| 40242772 | Case Report: Successful treatment of severe Guillain-Barré syndrome with paralytic ileus as a presenting symptom by intensive immunotherapy. | Front Immunol | 2025 | https://conductscience.org/library/papers/40242772 | PubMed |
| 40237241 | Brain-Derived Tau as an Outcome Marker in Guillain-Barré Syndrome: A Retrospective Cohort Study. | Eur J Neurol | 2025 | https://conductscience.org/library/papers/40237241 | PubMed |
| 38752584 | Guillain-Barré syndrome: History, pathogenesis, treatment, and future directions. | Eur J Neurol | 2024 | https://conductscience.org/library/papers/38752584 | PubMed |
| 37891867 | Usefulness and Clinical Impact of Whole-Body MRI in Detecting Autoimmune Neuromuscular Disorders. | Brain Sci | 2023 | https://conductscience.org/library/papers/37891867 | PubMed |
| 37847215 | Granuloma, vasculitis, and demyelination in sarcoid neuropathy. | Eur J Neurol | 2024 | https://conductscience.org/library/papers/37847215 | PubMed |
| 37356965 | Pathology explains various mechanisms of auto-immune inflammatory peripheral neuropathies. | Brain Pathol | 2024 | https://conductscience.org/library/papers/37356965 | PubMed |
| 37278272 | Progress in Guillain-Barré syndrome immunotherapy-A narrative review of new strategies in recent years. | Hum Vaccin Immunother | 2023 | https://conductscience.org/library/papers/37278272 | PubMed |
| 37139032 | Atypical Guillain-Barre Syndrome With a Sensory Level and Hyper-Acute Presentation: A Case Report. | Cureus | 2023 | https://conductscience.org/library/papers/37139032 | PubMed |
| 37108447 | Immune-Mediated Neuropathies: Pathophysiology and Management. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108447 | PubMed |
| 36569912 | Sex differences in Guillain Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis. | Front Immunol | 2022 | https://conductscience.org/library/papers/36569912 | PubMed |
| 36523267 | Complement inhibition prevents glial nodal membrane injury in a GM1 antibody-mediated mouse model. | Brain Commun | 2022 | https://conductscience.org/library/papers/36523267 | PubMed |
| 36133742 | Role of the Neutrophil to Lymphocyte Ratio in Guillain Barré Syndrome: A Systematic Review and Meta-Analysis. | Mediators Inflamm | 2022 | https://conductscience.org/library/papers/36133742 | PubMed |
| 36046684 | Emerging Role of Neuron-Glia in Neurological Disorders: At a Glance. | Oxid Med Cell Longev | 2022 | https://conductscience.org/library/papers/36046684 | PubMed |
| 34549385 | Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP. | Neurotherapeutics | 2021 | https://conductscience.org/library/papers/34549385 | PubMed |
| 33584245 | The Neuroimmunology of Guillain-Barré Syndrome and the Potential Role of an Aging Immune System. | Front Aging Neurosci | 2020 | https://conductscience.org/library/papers/33584245 | PubMed |
| 33359733 | New evidence for secondary axonal degeneration in demyelinating neuropathies. | Neurosci Lett | 2021 | https://conductscience.org/library/papers/33359733 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5769741
GET https://conductscience.org/api/papers/v1/5769741/cited_by?page=2